Back to search

Article

A novel molecular classification based on TP53 mutation to predict bladder cancer prognosis and immunotherapy efficacy

2024-02-06

Abstract excerpt

<h4>Background: </h4> The efficacy of TP53, the most widely researched mutation genetic genes in tumor, in tumor metabolic reprogramming remains unclear. Methods The differential analysis of gene expression data information of TP53 mutation and TP53 wild-type patients were conducted to identify TP53 mutation-associated metabolic genes (TMGs), which were used to identify and verify a TP53 mutation-associated metab...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
43ad22eb-3d8d-5573-a997-3156eb527d66
DOI
10.21203/rs.3.rs-3819403/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A novel molecular classification based on TP53 mutation to predict bladder cancer prognosis and immunotherapy efficacyDOI 10.21203/rs.3.rs-3819403/v1
Construction and validation of a prognostic model of metabolism-related genes driven by somatic mutation in bladder cancerSemantic proximity
Introduction of mutant TP53 related genes in metabolic pathways and evaluation their correlation with immune cells, drug resistance and sensitivity.Semantic proximity
Characterization of the metabolic alteration-modulated tumor microenvironment mediated by TP53 mutation and hypoxia.Semantic proximity
Metabolic‐associated signature and hub genes associated with immune microenvironment and prognosis in bladder cancerSemantic proximity
Construction and Validation of a Prognostic Model of Metabolism-Related Genes Driven by Somatic Mutation in Bladder Cancer.Semantic proximity
Identification of Metabolic Reprogramming Related Gene Signature to Predict the Prognosis of Bladder Cancer PatientsSemantic proximity
Metabolic-Associated Signature and Hub Genes Associated with Immune Microenvironment and Prognosis in Bladder CancerSemantic proximity
Immunometabolism characteristics and a potential prognostic risk model associated with TP53 mutations in breast cancer.Semantic proximity
Identification of metabolism-associated genes and construction of a prognostic signature in bladder cancerSemantic proximity
Glucose Metabolic Reprogramming in Cancer MicroenvironmentSemantic proximity
Identification of metabolism-associated genes and construction of a prognostic signature in bladder cancerSemantic proximity
Identification and experimental validation of biomarkers associated with amino acid metabolism and ferroptosis in bladder cancerSemantic proximity
Select a neighboring publication to make it the new centre.